Nami Okamoto

5PUBLICATIONS
17CO-AUTHORS
AllergyToxicology (incl. clinical toxicology)PharmacogenomicsInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 19, 2026
Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study.

|Mar 07, 2025
Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study.

Masataka Kuwana, Naonobu Sugiyama, Shigeki Momohara

|Aug 09, 2024
Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case postmarketing surveillance study.

Nami Okamoto, Tatsuya Atsumi, Michiaki Takagi

|Aug 29, 2020
Clinical practice guidance for Sjögren's syndrome in pediatric patients (2018) - summarized and updated.

Minako Tomiita, Ichiro Kobayashi, Yasuhiko Itoh

|Aug 22, 2018
Clinical practice guidance for juvenile idiopathic arthritis (JIA) 2018.

Nami Okamoto, Shumpei Yokota, Syuji Takei

Pageof 1

Frequent Collaborators

3 joint publications

Masataka Kuwana

3 joint publications

Michiaki Takagi

3 joint publications

Naoto Tamura

3 joint publications

Yoshiya Tanaka